The effect of nutritional therapy on the utilization of an intravenous fat emulsion was studied in patients with injury, infection, and nutritional depletion using 1-'4C-trioleate labeled Intralipid. The plasma fractional removal rate and '4C-Intralipid oxidation rate was 55% and 25% higher, respectively, in patients following trauma and during periods of infection receiving 5% dextrose than in healthy control subjects. Total parenteral nutrition (TPN) was administered as either 1) nonprotein calories given as glucose (Glucose System) or 2) equal proportions of glucose and intravenous fat emulsion (Lipid System). In comparison to TPN with the Lipid System, administration using the Glucose System resulted in higher plasma clearance rates and lower oxidation rates in both acutely ill and depleted patients. There was no correlation between the rates of plasma removal and oxidation of the intravenous fat emulsion (r = -0.04; NS) indicating that the removal of exogenous fat from plasma cannot be used as an indicator of oxidation. A negative linear relationship was seen between the oxidation rate of intravenous fat and carbohydrate intake (r = -0.92; p < 0.001). Glucose intakes exceeding energy expenditure did not totally inhibit oxidation of the fat emulsion. The oxidation rate of '4C-Intralipid was linearly related to net whole body fat oxidation calculated using indirect calorimetry (r = -0.90; p < 0.001) suggesting that the fat emulsion was oxidized in a similar manner to endogenous lipids.
The effect of nutritional therapy on the utilization of an intravenous fat emulsion was studied in patients with injury, infection, and nutritional depletion using 1-'4C-trioleate labeled Intralipid. The plasma fractional removal rate and '4C-Intralipid oxidation rate was 55% and 25% higher, respectively, in patients following trauma and during periods of infection receiving 5% dextrose than in healthy control subjects. Total parenteral nutrition (TPN) was administered as either 1) nonprotein calories given as glucose (Glucose System) or 2) equal proportions of glucose and intravenous fat emulsion (Lipid System). In comparison to TPN with the Lipid System, administration using the Glucose System resulted in higher plasma clearance rates and lower oxidation rates in both acutely ill and depleted patients. There was no correlation between the rates of plasma removal and oxidation of the intravenous fat emulsion (r = -0.04; NS) indicating that the removal of exogenous fat from plasma cannot be used as an indicator of oxidation. A negative linear relationship was seen between the oxidation rate of intravenous fat and carbohydrate intake (r = -0.92; p < 0.001). Glucose intakes exceeding energy expenditure did not totally inhibit oxidation of the fat emulsion. The oxidation rate of '4C-Intralipid was linearly related to net whole body fat oxidation calculated using indirect calorimetry (r = -0.90; p < 0.001) suggesting that the fat emulsion was oxidized in a similar manner to endogenous lipids.
This study suggests that intravenous fat emulsions are utilized as an energy substrate in patients with major injury, infection or nutritional depletion. This observation, along with a relative unresponsiveness to glucose in surgical patients suggests that fat emulsions may be useful as a calorie source in patients receiving parenteral nutrition.
HE NONPROTEIN CALORIES of total parenteral nutrition (TPN) may be given as hypertonic glucose solution or as a combination of intravenous fat emulsion and glucose. Artificial fat emulsions have the advantage of a high caloric content and osmolarity near that of plasma, which can obviate the need for central venous catherization. Furthermore, substitution of part of the glucose calories with intravenous fat may reduce undesirable effects that are sometimes seen with hypertonic glucose such as hypoglycemia and hyperglycemia, excessive CO2 production" 2 and increased urinary excretion of norepinephrine.32
The soybean-based fat emulsion Intralipid is widely used as a source of essential fatty acids for patients who require parenteral nutrition and can also be used as a major calorie source. Intralipid resembles natural chylomicrons with respect to droplet size,22 plasma removal kinetics,2' and interaction with the enzyme lipoprotein lipase. 4 Tables 1 and 2 . There was no significant weight loss in the patients with major injury except for patient no. 20 ( Table 1 ). The patients studied during periods of infection had a significant weight loss (10-20%) before study. The mean REE was 6% above predicted in the combined traumatized/infected group. All of the depleted patients had a history of substantial weight loss (14-59%) with a REE that averaged 14% 222 NORDENSTROM AND OTHERS below predicted values ( Table 2 ). Four normal male subjects (age 54 ± 7 (SEM); weight 85.0 ± 3.6 kg) were studied in the postabsorptive state to obtain control data.
Upon admission to the study, patients received an infusion of 5% dextrose solution. Daily measurements of 02 consumption, CO2 production, and nitrogen balance were instituted (see below). REE was calculated from measurements of gas exchange and N excretion using principles of indirect calorimetry. An intravenous fat tolerance test using labeled Intralipid ('4C-IVFTT) was performed during administration of 5% dextrose in 11 traumatized/infected patients. The initial 14C-IVFTT in the patients with major trauma was performed within 1 to 2 days of the actual injury. In these patients it was felt that the resumption of oral intake would not occur in the first week and infusion of TPN was instituted on the second day following the injury. The patients considered to be infected had a temperature above 102°F, and either clinical evidence of localized infection or a positive blood culture. Following administration of the assigned nutritional regimen for a 4 to 6-day period, a repeat '4C-IVFTT was performed on 14 occasions (seven during each nutritional regimen). The studies actually performed on each individual are shown in Table 1 .
In the patients with nutritional depletion studies were continued for up to 4 weeks. Each 14C-IVFTT was performed after 7 days of administration of the assigned dietary regimen. Eight studies were performed during administration of the Glucose System and five studies during administration of the Lipid System. The normal subjects were studied in the postabsorptive state. amino acids and glucose solutions were administered at a constant rate during the 24-hour period. Fat emulsions were infused in the late afternoon over a 6-to 8-hour period.
Measurements
Oxygen consumption and carbon dioxide production were measured using a rigid lucite head canopy system previously described.25'39 Measurements were performed 4 to 6 times each for 30 to 40 minutes, evenly spaced throughout the day. Resting energy expenditure and rates of substrate oxidation were calculated by standard procedures.'2'4' Predicted normal values for REE were obtained by adding 10% to the values obtained from conventional tables of basal metabolic rate. '6 The determination of nitrogen balance has been previously described in detail'0 and is briefly summarized.
All intake, whether oral or infused, was measured by difference in weight of full and emptied containers. one for injection of the fat emulsion and the other for withdrawal of blood samples. Both were maintained for the duration of the study with isotonic saline. Baseline blood samples were obtained (at least 40 minutes after catheter placement) for determination of free fatty acids (FFA), glucose, triglycerides (TG), insulin, glucagon, blood urea nitrogen, and baseline radioactivity. A bolus dose of 1 ml per kg body weight of Intralipid 10%, containing 36 uCi of 1-'4C-trioleate labeled Intralipid, was injected over a 60-second period. Blood samples for the determination of FFA, TG, '4C-FFA and '4C-TG, were obtained at 2, 4, 6, 8, 12, 20, 40 , and 60 minutes after the midpoint of the Intralipid infusion. Studies in patients receiving the Lipid system were performed before the daily administration of the unlabelled fat emulsion. Expired air was collected using the canopy system25 39 which measures expired radioactivity as well as the total excretion of unlabelled CO2. Expired air was collected for five to six periods averaging 30 to 40 minutes each, within the first 450 minutes following the injection.
The 1_-4C-Triolein labelled Intralipid was prepared by Vitrum AB (Stockholm, Sweden). The labelled triolein was added to the soy bean oil before incorporation into the fat emulsion. Specific activity was 4.0 u Ci/ 100 mg triglyceride, with more than 99% of the radioactivity in the triglyceride fraction.
Plasma clearance of intravenous fat was determined by the rate of disappearance of radioactivity in plasma TG. The rate constant for the fractional removal of the injected isotopic triglyceride was calculated from the computed least squares regression line (Ln '4C-TG vs. time).
The rate of oxidation of '4C-Intralipid was calculated from the cumulative 14C02 production which was obtained by integration under the curve of expired radioactivity. This rate is expressed as the fraction of administered dose oxidized within 450 minutes (%. 450 min-').
Statistical Methods Student's t test was used for the statistical analysis using the paired t test when applicable. Coefficients of correlation were determined by standard procedure. 38 Variance of the mean is expressed as the standard error of the mean (SEM).
Results
The results for the injured and infected patients were similar and, therefore, are presented together.
Plasma Clearance of Intralipid Fat Emulsion
The disappearance of plasma TG radioactivity was found to follow first order kinetics for the first 15 0.1% min-'; p < 0.01) (Fig. 1) . Plasma fractional removal rates were higher in the traumatized/infected patients than in the depleted patients receiving the comparable TPN formula, but these differences were not statistically significant. In the traumatized and infected group of patients, administration of TPN with the Lipid System was associated with a significantly decreased plasma clearance of lipid as compared with clearance during administration of 5% dextrose or the Glucose based regimen (Table 3 ). An increased fractional removal rate was observed with the Glucose System as compared with 5% dextrose infusion, but the results were not significant. The higher fractional removal rate observed during TPN with the Glucose System as compared with the Lipid System was also observed in the depleted patients (Table 4 ). Figure 2a shows the rate of elimination of TG radioactivity in plasma for the depleted patients. In the depleted patients in whom the '4C-IVFTT was performed during administration of both nutritional regimens, fractional removal rates were higher during administration of the Glucose System. From this figure it is also evident that the elimination of '4C-Intralipid follows first order kinetics during the 15 minutes. An increase in TG radioactivity is seen in some cases thereafter, probably caused by the appearance of recycled '4C-FFA in plasma TG. There was a statistically significant correlation between fractional While receiving 5% dextrose, the patients with trauma or infection had significantly higher oxidation rates of '4C-Intralipid (37.0 ± 1.1%) than healthy postabsorptive controls (29.5 ± 2.0% * 450 min-', p < 0.01). Changes in clearance and oxidation of the labelled fat emulsion responded in a qualitatively similar manner in both the trauma/septic and nutritionally depleted patients. However, quantitatively, the oxidation of '4C-Intralipid tended to be lower on any given diet in the nutritionally depleted patients (Fig. 3) . In all patients, the oxidation of intravenous fat was greater with the lipid than the Glucose System. Figure 2b shows the actual data for '4C-Intralipid oxidation in nutritionally depleted patients. In all patients, a higher oxidation rate of intravenous fat was seen with the Lipid System than with the Glucose System. The oxidation of '4C-Intra- (Fig. 4) . There was no correlation between oxidation and plasma clearance of exogenous fat (r = 0.04, NS). (Table 3) . Glucose levels increased significantly and FFA concentrations decreased during TPN. There was no significant difference in glucose, FFA, or TG levels between the two TPN diets in either group of patients (Tables 3 and 4) . During administration of TPN, insulin levels rose significantly from the values observed during the administration of 5% dextrose solution. The highest concentration, as expected, were observed during administration of the Glucose System. Insulin concentration was closely correlated to carbohydrate intake both in the traumatized/septic (r = 0.73, p < 0.01) and in the depleted patients (r = 0.64, p < 0.001). However, the depleted patients had significantly lower insulin levels than the traumatized/infected patients both with the Lipid System (p < 0.05) and the Glucose System (p < 0.001). Furthermore plasma glucose, FFA and TG levels tended to be lower in the depleted patients than in the traumatized/infected patients despite comparable carbohydrate intakes. Glucagon concentration was more than twice normal during 5% dextrose infusion in the traumatized/ (Fig. 5 ).
Discussion Plasma removal rate of intravenous fat was increased more than 50% in the traumatized and infected patients receiving hypocaloric dextrose infusions compared with normal postabsorptive patients. This increase in plasma clearance of fat emulsion after trauma is in agreement with the findings of Hallberg2' and the authors' previous studies.35 Plasma clearance of exogenous fat was also increased in the infected patients taken separately, and was not significantly different from that seen in the traumatized patients, in agreement with our previous findings.35 It It has been-suggested that the IVFTT may be a useful tool in such diseases as atherosclerosis, hypertriglycer-229 idemia,'4 and diabetes.26 However the IVFTT is of limited value in the study of energetics of lipid metabolism since it provides no information regarding the oxidation of intravenous fat emulsion. The use of a fat emulsion that has been radioactively labeled in its fatty acid moiety offers unique possibilities since final oxidation product, '4CO2, may be determined. The present study shows that "4CO2 appears within a few minutes after the injection of '4C-Intralipid indicating that this fat emulsion is readily used as an energy substrate. Mean oxidation rate of '4C-Intralipid after trauma and during infection was approximately 25% higher than in healthy control subjects. Thus, trauma and infection may not only be associated with an accelerated plasma clearance but also an increased oxidation of intravenous fat emulsion.
During TPN, intravenous fat emulsion may be infused together with glucose and amino acids in order to reduce complications caused by high osmolarity of the latter two solutions. Little information is available, however, concerning the influence of the simultaneous infusion of other nutrients in the metabolism of intravenous fat emulsions during TPN. In the present study, patients receiving TPN with the Glucose System had higher plasma clearance rates of intravenous fat than had the healthy postabsorptive subjects. Studies by others have shown that healthy subjects also have increased plasma removal of intravenous fat emulsion during glucose absorption.30 During TPN with the Lipid System, rates of fat emulsion were of similar magnitude as in the healthy postabsorptive controls (Fig. 1) .
For all patients, a close negative correlation was seen between intravenous fat oxidation and carbohydrate intake (Fig. 4) . In normals glucose and insulin effectively decrease the the oxidation of chylomicrons'8 and circulating plasma FFA.'9 Previous studies from this laboratory have shown that traumatized and infected patients have a continued oxidation of plasma FAA and whole body net fat oxidation despite the administration of glucose above energy requirements."3' In the present. study, oxidation of intravenous fat was also not entirely suppressed despite the administration of carbohydrate calories in excess of REE. Three patients receiving TPN with the Glucose System continued to oxidize '4C-Intralipid despite a net fat synthesis (indicated by negative values for net fat-oxidation) (Fig. 5) .
The observation that TPN with the glucose System increased the clearance of Intralipid but decreased oxidation indicates that the fat emulsion was removed from the circulation predominately for storage. The rate-determining enzyme for the clearance of fat emul- It has often been questioned whether the fate of exogenous fat emulsions after clearance from plasma is the same as for endogenously synthesized chylomicrons. In the present study there is a very close correlation between rates of oxidation of labelled Intralipid and whole body fat over a wide range of values and conditions. This indicates that exogenous fat emulsions are handled'5 in the same way after clearance from plasma as are endogenous fat stores and chylomicrons. Depleted as well as acutely ill patients have a metabolic status, directed toward the mobilization and oxidation of endogenous lipid stores."3' Traumatized and infected patients furthermore display a relative unresponsiveness to glucose with respect to net fat oxidation,l plasma FFA turnover and oxidation,3' and continued gluconeogenesis. " As shown in this study, intravenous fat emulsion is readily utilized and oxidized similarly to endogenous lipids. This observation, together with a relative glucose intolerance, suggests that a balanced intravenous nutritional support of glucose, exogenous fat, and amino acids may be a preferable approach for surgical patients in need of TPN.
